©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Pharmacol Ther. Feb 6, 2015; 6(1): 1-9
Published online Feb 6, 2015. doi: 10.4292/wjgpt.v6.i1.1
Published online Feb 6, 2015. doi: 10.4292/wjgpt.v6.i1.1
Prevention of pelvic radiation disease
Lorenzo Fuccio, Leonardo Frazzoni, Department of Medical and Surgical Sciences, S.Orsola-Malpighi Hospital, University of Bologna, 40136 Bologna, Italy.
Alessandra Guido, Division of Radiation Oncology, S.Orsola-Malpighi Hospital, University of Bologna, 40136 Bologna, Italy
Author contributions: All the authors equally contributed to the paper and approved the final version of the article.
Correspondence to: Lorenzo Fuccio, MD, Department of Medical and Surgical Sciences, S.Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40136 Bologna, Italy. lorenzofuccio@gmail.com
Telephone: +39-51-6363338 Fax: +39-51-6363338
Received: June 6, 2014
Peer-review started: June 8, 2014
First decision: July 10, 2014
Revised: September 2, 2014
Accepted: November 7, 2014
Article in press: November 10, 2014
Published online: February 6, 2015
Processing time: 242 Days and 19.9 Hours
Peer-review started: June 8, 2014
First decision: July 10, 2014
Revised: September 2, 2014
Accepted: November 7, 2014
Article in press: November 10, 2014
Published online: February 6, 2015
Processing time: 242 Days and 19.9 Hours
Core Tip
Core tip: Radiotherapy is a treatment of choice in the management of several pelvic cancers. Acute and late-onset radiation-induced gastrointestinal toxicity, also known as pelvic radiation disease, is still frequently observed, despite recent improvements in radiation techniques. In the current review we provide an updated overview on the medical therapies that have been investigated with preventive intents, focusing our attention on the best available evidences, primarily randomized controlled studies.